6th Annual RAS-Targeted Drug Development Summit
![](/media/18089/2464057_2_300.jpg?anchor=center&mode=crop&width=300&height=300&rnd=133622456770000000)
-
Location:
- Hilton Boston Park Plaza
- 50 Park Plaza
- Boston
- Massachusetts
- 02116
- United States
- View on a map
- More Information:
-
Contact:
- Organiser: Hanson Wade Group
- Name: Nell Sydenham
- Email: info@hansonwade.com
- Telephone: +442031418700
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance. However, treating patients with RAS mutant cancers remains no easy feat, as knowledge gaps persist in improving the depth and durability of response, tackling emerging resistance mechanisms and informing combination strategies to improve the standard-of care for patients in need.
Owing to this, the 6th Annual RAS-Targeted Drug Development Summit returns as the central hub dedicated to every aspect of discovery and development of RAS, from discovery and clinical development through to commercialization, equipping 200+ global RAS leaders with the means to create effective frontline RAS therapies for better patient outcomes.
Date and Time: Tuesday, 24 September 2024 at 08:00 to Thursday, 26 September 2024 at 16:45